Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.690
+0.010 (0.60%)
At close: Oct 26, 2026, 4:00 PM EDT
1.630
-0.060 (-3.55%)
Pre-market: Oct 27, 2026, 4:01 AM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $201.88 million as of October 26, 2026. It is the 20,563rd most valuable company in the world and the 3,552nd biggest in the United States. Its market cap has decreased by 5.92% in one year.
Market Cap
201.88M
Enterprise Value
186.72M
1-Year Change
-5.92%
Global Rank
Country Rank
#3,552 United States
Category
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $201.88M, a decrease of -61.45%. That is a compound annual growth rate of -17.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 201.88M | 181.94% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 226.67M |
| Keros Therapeutics | 226.43M |
| Palisade Bio | 224.81M |
| Lexeo Therapeutics | 221.92M |
| BridgeBio Oncology Therapeutics | 212.06M |
| Camp4 Therapeutics | 204.58M |
| Protalix BioTherapeutics | 201.03M |
| Zentalis Pharmaceuticals | 199.76M |